Literature DB >> 12624717

A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes.

M Mochi1, S Cevoli, P Cortelli, G Pierangeli, S Soriani, C Scapoli, P Montagna.   

Abstract

We assessed the role of some dopamine metabolism genes in the genetic susceptibility to migraine. We performed an association study using three functional polymorphisms: a 48-base-pair (bp) tandem repeat in the D4 dopamine receptor gene ( DRD4), a 40-bp tandem repeat in the dopamine transporter gene ( DAT) and a dinucleotide repeat in the dopamine beta-hydroxylase ( DBH) gene. Allelic and genotypic frequencies for each polymorphism were assayed in two migraine populations (93 individuals with migraine with aura (MA) and 101 with migraine without aura (MO)) and were compared with those in a control group (117 individuals). No significant differences were found between control and migraine groups for DAT and DBH polymorphisms. Instead, the distribution of alleles for the DRD4 gene in the MO group was significantly different from those in both MA and control groups, with the shortest and longest alleles being less frequent in MO. Our data indicate that MO, but not MA, shows significant genetic association with DRD4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624717     DOI: 10.1007/s100720300005

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  19 in total

1.  Genomewide significant linkage to migrainous headache on chromosome 5q21.

Authors:  Dale R Nyholt; Katherine I Morley; Manuel A R Ferreira; Sarah E Medland; Dorret I Boomsma; Andrew C Heath; Kathleen R Merikangas; Grant W Montgomery; Nicholas G Martin
Journal:  Am J Hum Genet       Date:  2005-07-28       Impact factor: 11.025

Review 2.  Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems.

Authors:  Ellen W Yeung; Jason G Craggs; Ian R Gizer
Journal:  Alcohol Clin Exp Res       Date:  2017-10-19       Impact factor: 3.455

3.  Migraine genetics: current findings and future lines of research.

Authors:  A M Persico; M Verdecchia; V Pinzone; V Guidetti
Journal:  Neurogenetics       Date:  2014-12-14       Impact factor: 2.660

4.  Association between migraine and a functional polymorphism at the dopamine beta-hydroxylase locus.

Authors:  F Fernandez; N Colson; S Quinlan; J MacMillan; R A Lea; L R Griffiths
Journal:  Neurogenetics       Date:  2009-02-14       Impact factor: 2.660

5.  Current issues in migraine genetics.

Authors:  Jee-Young Lee; Manho Kim
Journal:  J Clin Neurol       Date:  2005-04-30       Impact factor: 3.077

6.  Lack of association between five serotonin metabolism-related genes and medication overuse headache.

Authors:  Sabina Cevoli; Nadia Marzocchi; Sabina Capellari; Chiara Scapoli; Giulia Pierangeli; Daniela Grimaldi; Federica Naldi; L Alberto Pini; Pasquale Montagna; Pietro Cortelli
Journal:  J Headache Pain       Date:  2010-02       Impact factor: 7.277

Review 7.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

Review 8.  Dopaminergic symptoms in migraine.

Authors:  Piero Barbanti; L Fofi; C Aurilia; G Egeo
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

9.  New genetic evidence for involvement of the dopamine system in migraine with aura.

Authors:  Unda Todt; Christian Netzer; Mohammad Toliat; Axel Heinze; Ingrid Goebel; Peter Nürnberg; Hartmut Göbel; Jan Freudenberg; Christian Kubisch
Journal:  Hum Genet       Date:  2009-01-17       Impact factor: 4.132

10.  Two-stage case-control association study of dopamine-related genes and migraine.

Authors:  Roser Corominas; Marta Ribases; Montserrat Camiña; Ester Cuenca-León; Julio Pardo; Susana Boronat; María-Jesús Sobrido; Bru Cormand; Alfons Macaya
Journal:  BMC Med Genet       Date:  2009-09-21       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.